Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - REVENUE
Revenue FOLD - Amicus Therapeutics, Inc.
528 M
LAST VALUE
26.67%
2 YEAR CAGR
23.72%
5 YEAR CAGR
83.45%
10 YEAR CAGR